Stocks and Investing
Stocks and Investing
Mon, June 3, 2024
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Fri, May 31, 2024
[ 12:00 AM ] - United States, WOPRAI
Yigal Nochomovitz Maintained (SMMT) at Strong Buy with Increased Target to $13 on, May 31st, 2024
Yigal Nochomovitz of Citigroup, Maintained "Summit Therapeutics Inc." (SMMT) at Strong Buy with Increased Target from $7 to $13 on, May 31st, 2024.
Yigal has made no other calls on SMMT in the last 4 months.
There is 1 other peer that has a rating on SMMT. Out of the 1 peers that are also analyzing SMMT, 0 agree with Yigal's Rating of Hold.
This is the rating of the analyst that currently disagrees with Yigal
- Bradley Canino of "Stifel" Initiated at Strong Buy and Held Target at $8 on, Tuesday, March 26th, 2024
Contributing Sources